GMP Cell Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

The global GMP cell banking services market is witnessing significant growth, with the mammalian cell type segment taking the lead in terms of revenue and attractiveness. This trend is projected to continue throughout the forecast period, highlighting the pivotal role of mammalian cell banking services in the biopharmaceutical industry.

Mammalian Segment Dominates and Continues to Thrive

The mammalian cell type segment has asserted its dominance in the global GMP cell banking services market, contributing to over 60% of the total revenue share. This segment's attractiveness is evident with an attractiveness index of 5, indicating its strong potential over the forecast period. By 2031, the mammalian segment is expected to further solidify its position by gaining 556 basis points in market share and achieving remarkable growth, set to increase by 3.2 times.

Driving Factors

Limited in-house storage and testing capabilities have emerged as a primary driver for the global GMP cell banking services market. Global biopharmaceutical companies are increasingly turning to outsourcing as they seek to enhance operational efficiency and boost pipeline productivity. Small biotechnology firms, backed by venture capital and larger biopharmaceutical companies, are at the forefront of discovering promising new therapies. These organizations continue to invest in their pipelines, bolstered by ongoing funding availability.

Biopharmaceutical companies often prefer to outsource manufacturing activities in regions where they lack expertise, particularly in the later stages of the value chain. Collaborating with Contract Development and Manufacturing Organizations (CDMOs) grants them access to extensive distribution networks and knowledge of regulatory guidelines, driving market growth.

Moreover, large biopharmaceutical companies with multiple manufacturing sites face limitations in in-house storage of GMP cell banks. Cell banking service providers offer dedicated infrastructure, including clean rooms and expert personnel, ensuring compliance with regulatory standards such as ICH. They also provide in-house testing services or subcontract to certified laboratories, further propelling the global GMP cell banking services market.

Regional Dominance of Mammalian Cell Type Segment

North America: The mammalian cell type segment has established its dominance in the North America GMP cell banking services market in terms of revenue and is poised to maintain this position throughout the forecast period. With an attractiveness index of 5.1, it remains the most attractive segment in the region.

Latin America: In the Latin America GMP cell banking services market, the mammalian segment also takes the lead with an attractiveness index of 4.5, underscoring its significance in the regional landscape.

Europe: Revenue from the mammalian segment in the Europe GMP cell banking services market is expected to surpass US$ 200 million by 2031, highlighting its robust growth trajectory.

Asia Pacific: The mammalian segment continues to dominate the Asia Pacific GMP cell banking services market, further strengthening its position.

The global GMP cell banking services market is witnessing a significant shift, with the mammalian cell type segment emerging as a key driver of growth and innovation in the biopharmaceutical industry.

Market Segmentation

By Cell Type

Mammalian
Microbial
Insect
Yeast
Avian
Stem Cell
Others

By End User

Biopharmaceutical Companies
Contract Manufacturing Organizations

By Region

North America
Latin America
Europe
Asia Pacific
MEA

1. Executive Summary

1.1. Global GMP Cell Banking Service Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global GMP Cell Banking Service Market Outlook, 2018 - 2031

3.1. Global GMP Cell Banking Service Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Mammalian
  - 3.1.1.2. Microbial
  - 3.1.1.3. Insect
  - 3.1.1.4. Yeast
  - 3.1.1.5. Avian
  - 3.1.1.6. Stem Cell
  - 3.1.1.7. Others
3.2. Global GMP Cell Banking Service Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Biopharmaceutical Companies
  - 3.2.1.2. Contract Manufacturing Organizations
3.3. Global GMP Cell Banking Service Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America GMP Cell Banking Service Market Outlook, 2018 - 2031

4.1. North America GMP Cell Banking Service Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Mammalian
  - 4.1.1.2. Microbial
  - 4.1.1.3. Insect
  - 4.1.1.4. Yeast
  - 4.1.1.5. Avian
  - 4.1.1.6. Stem Cell
  - 4.1.1.7. Others
4.2. North America GMP Cell Banking Service Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Biopharmaceutical Companies
  - 4.2.1.2. Contract Manufacturing Organizations Others
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America GMP Cell Banking Service Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 4.3.1.2. U.S. GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 4.3.1.3. Canada GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 4.3.1.4. Canada GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe GMP Cell Banking Service Market Outlook, 2018 - 2031

5.1. Europe GMP Cell Banking Service Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Mammalian
  - 5.1.1.2. Microbial
  - 5.1.1.3. Insect
  - 5.1.1.4. Yeast
  - 5.1.1.5. Avian
  - 5.1.1.6. Stem Cell
  - 5.1.1.7. Others
5.2. Europe GMP Cell Banking Service Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Biopharmaceutical Companies
  - 5.2.1.2. Contract Manufacturing Organizations
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe GMP Cell Banking Service Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.2. Germany GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.3.1.3. U.K. GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.4. U.K. GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.3.1.5. France GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.6. France GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.3.1.7. Italy GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.8. Italy GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.3.1.9. Turkey GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.10. Turkey GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.3.1.11. Russia GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.12. Russia GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.3.1.13. Rest of Europe GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 5.3.1.14. Rest of Europe GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific GMP Cell Banking Service Market Outlook, 2018 - 2031

6.1. Asia Pacific GMP Cell Banking Service Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Mammalian
  - 6.1.1.2. Microbial
  - 6.1.1.3. Insect
  - 6.1.1.4. Yeast
  - 6.1.1.5. Avian
  - 6.1.1.6. Stem Cell
  - 6.1.1.7. Others
6.2. Asia Pacific GMP Cell Banking Service Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Biopharmaceutical Companies
  - 6.2.1.2. Contract Manufacturing Organizations
- 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific GMP Cell Banking Service Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.2. China GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.3.1.3. Japan GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.4. Japan GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.3.1.5. South Korea GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.6. South Korea GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.3.1.7. India GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.8. India GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.3.1.9. Southeast Asia GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.10. Southeast Asia GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America GMP Cell Banking Service Market Outlook, 2018 - 2031

7.1. Latin America GMP Cell Banking Service Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Mammalian
  - 7.1.1.2. Microbial
  - 7.1.1.3. Insect
  - 7.1.1.4. Yeast
  - 7.1.1.5. Avian
  - 7.1.1.6. Stem Cell
  - 7.1.1.7. Others
7.2. Latin America GMP Cell Banking Service Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America GMP Cell Banking Service Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.2. Brazil GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.3.1.3. Mexico GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.4. Mexico GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.3.1.5. Argentina GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.6. Argentina GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa GMP Cell Banking Service Market Outlook, 2018 - 2031

8.1. Middle East & Africa GMP Cell Banking Service Market Outlook, by Cell Type, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Mammalian
  - 8.1.1.2. Microbial
  - 8.1.1.3. Insect
  - 8.1.1.4. Yeast
  - 8.1.1.5. Avian
  - 8.1.1.6. Stem Cell
  - 8.1.1.7. Others
8.2. Middle East & Africa GMP Cell Banking Service Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Biopharmaceutical Companies
  - 8.2.1.2. Contract Manufacturing Organizations
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa GMP Cell Banking Service Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.2. GCC GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.3.1.3. South Africa GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.4. South Africa GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.3.1.5. Egypt GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.6. Egypt GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.3.1.7. Nigeria GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.8. Nigeria GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa GMP Cell Banking Service Market by Cell Type, Value (US$ Mn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa GMP Cell Banking Service Market by End User, Value (US$ Mn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. WuXi AppTec
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Charles River Laboratories International, Inc
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Eurofins Scientific
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Merck KGaA
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Lonza Group Ltd
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. SGS Ltd
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. ViruSure GmbH
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Austrianova
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Goodwin Biotechnology Inc.
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Paragon Bioservices, Inc.
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations